Nevertheless, not all papers found a reduction of these immune-inflammatory biomarkers after treatment and could find significant differences between patients in an acute phase of depression and those who were euthymic (Maes 2011), suggesting that increased levels of cytokines (including IL-6 and sIL-6R) are trait markers of major depression. This evidence concerns the gene IL6R and depressive disorder.